NCT04395131View on ClinicalTrials.gov

Clearum High Flux Hemodialyzer Used in Hemodialysis for Subjects With End-Stage Renal Disease

NACompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 3, 2020

Primary Completion Date

August 14, 2020

Study Completion Date

August 14, 2020

Conditions

End-stage Renal Disease

Interventions

DEVICE

Clearum HF Hemodialyzer

the hemodialyzer will be used 3x week for 3.5-4.5 hours with a Qb of at least 350 ml/min

Trial Locations (1)

D-40201

DaVita Clinical Research Germany, Düsseldorf

Sponsors

Lead Sponsor

Medtronic - MITG

All Listed Sponsors

lead

Medtronic - MITG

INDUSTRY